
FAMILY HISTORY AS AN IMPORTANT FACTOR
FOR STRATIFYING PARTICIPANTS IN GENETIC
STUDIES OF MAJOR DEPRESSION Zalar B, Blatnik A, Maver A, Klemenc-Ketiš Z, Peterlin B *Corresponding Author: Professor Borut Peterlin, Clinical Institute of Medical Genetics, Division of Obstetrics and Gynecology,
University Medical Center Ljubljana, Šlajmerjeva 3, 1000 Ljubljana, Slovenia. Tel: +386-1-5401-137. E-mail:
borut.peterlin@guest.arnes.si page: 5 download article in pdf format
|
Abstract
Depression is estimated to affect 350 million people
worldwide. The World Mental Health Survey conducted
in 17 countries found that, on average, about one in 20
people reported having an episode of depression in the
previous year. Although depression has been shown to be
moderately heritable by studies conducted in the past, the
search for its so-called missing heritability has so far been
unsuccessful. The difficulty in identifying common genetic
variants predisposing to depression could be due to large
sample sizes needed to detect small effects on genetic risk
and the heterogeneous nature of major depressive disorder
(MDD). The aim of our study was to determine whether
there was a connection between a family history of depression
in MDD patients and the presence of putative risk
variants in the well-studied SLC6A4, COMT and PCLO
genes. We analyzed 133 patients with MDD (30.0% with
a positive family history for MDD and 70.0% sporadic
cases) and compared them to 279 healthy controls. When
comparing all the depressed patients to controls, no significant
differences in genotype and allele distributions were
detected. After stratifying patients according to their family
history, the PCLO rs2522833 C allele was shown to be
significantly less common in patients with a positive family
history (p = 0.001), indicating a possible difference in the
genetic structure of MDD between familial and sporadic
cases and a less important role of the common genetic risk
variants for the development of MDD in familial cases.
Keywords: COMT gene; Family history; Major depressive
disorder (MDD); PCLO gene; SLC6A4 gene.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|